SCHEMBL10206649

SCHEMBL10206649

Cc1c(Nc2ncc(Cl)c(NCc3cccc4c3C(C)(C)C(=O)N4)n2)ccc(C2CCCN(CC(C)(C)O)C2)c1C

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 6/20 0.36
▸ JAK3 P52333 7/20 0.36
▸ JAK1 P23458 2/20 0.35
▸ JAK2 O60674 2/20 0.34
▸ EGFR P00533 2/20 0.34
▸ TTK P33981 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ TXK P42681 1/20 0.34
▸ BLK P51451 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ ITK Q08881 1/20 0.34
▸ MAPK3 P27361 1/20 0.34
▸ LRRK2 Q5S007 2/20 0.32
▸ AURKA O14965 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ TNK2 Q07912 1/20 0.32
▸ ALK Q9UM73 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10207051 0.95 NTRK1 (0.37) NTRK1JAK3JAK1JAK2EGFR
SCHEMBL10206623 0.93 JAK3 (0.37) JAK3JAK1JAK2EGFRTTK
SCHEMBL10206651 0.92 PTK2 (0.39) NTRK1JAK3JAK2LRRK2
SCHEMBL10207052 0.90 JAK3 (0.35) NTRK1JAK3JAK1JAK2EGFR
SCHEMBL10206630 0.90 JAK3 (0.37) NTRK1JAK3JAK1JAK2EGFR
SCHEMBL10206187 0.88 EGFR (0.45) JAK3JAK1JAK2EGFRTTK
SCHEMBL10206653 0.87 PTK2 (0.39) NTRK1JAK3JAK2LRRK2
SCHEMBL10205874 0.84 PTK2 (0.39) NTRK1JAK3JAK2EGFRLRRK2
SCHEMBL10205180 0.84 EGFR (0.41) JAK3JAK1JAK2EGFRTTK
SCHEMBL10206638 0.83 ALK (0.42) JAK3FLT3ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2655358-B1 OXINDOLOPYRIMIDINE AS IGF1R RECEPTOR INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 — — EP disclosed
US-8546443-B2 Benzylic oxindole pyrimidines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-10-01 — — US disclosed
WO-2012085126-A1 OXINDOLOPYRIMIDINE AS IGF1R RECEPTOR INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-28 — — WO disclosed
Send feedback